Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2014

Jan 3, 2014

30016_dirs_2014-01-03_5c204d01-6f46-4983-8e86-711772cfe112.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-01-01

Reporting Person: MCKEON BRIAN P (Executive VP, CFO & Treasurer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-01-01 Non-Qualified Stock Option (right to buy) $106.3700 A 18918 Acquired 2023-12-31 Common Stock (18918) Direct
2014-01-01 Incentive Stock Option (right to buy) $106.3700 A 4700 Acquired 2023-12-31 Common Stock (4700) Direct
2014-01-01 Restricted Stock Unit $ A 7051 Acquired Common Stock (7051) Direct

Footnotes

F1: Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (01/01/2015) of the date of grant.

F2: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (01/01/2015) of the date of grant.